Related Experiment Videos
[The best of pediatric cardiology in 2002]
1Hôpital cardiologique du Haut-Lévêque, avenue de Magellan, 33604 Pessac.
Insights
Interventional cardiology advances congenital heart disease treatment. Percutaneous closure effectively treats atrial defects and patent foramen ovale, improving patient outcomes and reducing events.
Area of Science:
- Interventional Cardiology
- Congenital Heart Disease
- Pediatric Cardiology
Context:
- Significant advancements in interventional cardiology for congenital heart disease over the past year.
- Established percutaneous closure techniques for ostium secundum atrial defects yield excellent results.
- Ongoing debate regarding patent foramen ovale (PFO) closure for paradoxical embolism, yet studies show reduced ischemic events.
Purpose:
- To review recent progress in interventional cardiology for congenital heart disease.
- To highlight the efficacy of percutaneous closure for specific defects and syndromes.
- To discuss emerging areas and future directions in the field.
Summary:
- Percutaneous closure is now a standard treatment for ostium secundum atrial defects.
- Patent foramen ovale (PFO) closure shows promise in reducing ischemic events and treating platypnoea-orthodeoxia syndrome.
- Complex procedures like ventricular septal defect closure and valve replacement require further evaluation.
Impact:
- Improved treatment options for patients with congenital heart defects.
- Potential reduction in morbidity and mortality associated with specific cardiac conditions.
- Advancements in fetal cardiology, sudden death studies, and adult congenital heart disease care.
Abstract:
This past year has been remarkable for considerable advance in the field of interventional cardiology for congenital heart disease. Ostium secundum atrial defect is by now cured by percutaneous closure with excellent results. Closure of patent foramen ovale (PFO) in patients with paradoxical embolism is still controversial. Nevertheless, some studies demonstrate the efficiency of this procedure, reducing the incidence of ischemic events. In cases of platypnoea-orthodeoxia syndrome occurring in patients having undergone pneumonectomy or presenting dilatation of ascending aorta, closure of PFO with an occluder gives spectacular results with disappearance of dyspnea and cyanosis. Other more complex procedures such as closure of membranous ventricular septal defect, replacement of an pulmonary or aortic valve are still to be assessed. As the last point let us underline the progress of foetal cardiology, the studies of sudden death in children an adolescents, and the care of adults with congenital heart disease.